CD8+ memory T cells predominate over naïve T cells in therapy-free CML patients with sustained major molecular response
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference7 articles.
1. Discontinuation of imatinib therapy after achieving a molecular response;Cortes;Blood,2004
2. Divergent clinical outcome in two CML patients who discontinued imatinib therapy after achieving a molecular remission;Mauro;Leukemia Res,2004
3. CML cytogenetic relapse after cessation of imatinib therapy;Usuki;Leukemia Res,2005
4. Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years;Rousselot;Blood,2007
5. Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders;Bonifazi;Blood,2001
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunological off-target effects of imatinib;Nature Reviews Clinical Oncology;2016-03-31
2. The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses;Molecular Cancer Therapeutics;2015-03-11
3. Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy;PLoS ONE;2014-01-31
4. Long-term molecular remission with persistence ofBCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL;British Journal of Haematology;2013-10-18
5. Increased natural killer cells and decreased CD3+CD8+CD62L+ T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib;British Journal of Haematology;2011-11-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3